Identifying genotype-phenotype correlations involves a combination of genetic testing, clinical observation, and bioinformatics. Techniques such as next-generation sequencing (NGS) allow for comprehensive genetic profiling of tumors, revealing mutations that may be driving the cancer. Coupled with clinical data, researchers can determine correlations between specific genetic alterations and clinical outcomes.
